Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 108,664 | 108,663 | 105,171 | 111,171 | 108,864 |
| Cost of Goods | 59,941 | 59,319 | 57,475 | 58,831 | 58,672 |
| Gross Profit | 48,723 | 49,344 | 47,696 | 52,340 | 50,192 |
| Operating Expenses | 51,377 | 43,045 | 46,634 | 45,341 | 42,459 |
| Operating Income | -1,713 | 6,618 | 1,537 | 7,830 | 8,405 |
| Interest Expense | 846 | 990 | 955 | 584 | 752 |
| Other Income | -1,049 | -1,211 | -147 | -354 | -785 |
| Pre-tax Income | -3,608 | 4,417 | 435 | 6,892 | 6,868 |
| Income Tax | 15,431 | 2,062 | -288 | 2,398 | 1,579 |
| Net Income Continuous | -19,039 | 2,355 | 723 | 4,494 | 5,289 |
| Net Income Discontinuous | N/A | N/A | -2,553 | -2,124 | -1,477 |
| Net Income | $-19,039 | $2,355 | $-1,830 | $2,370 | $3,812 |
| EPS Basic Total Ops | -5.70 | 0.70 | -0.60 | 0.90 | 1.40 |
| EPS Basic Continuous Ops | -5.67 | 0.73 | 0.20 | 1.60 | 1.90 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.80 | -0.70 | -0.50 |
| EPS Diluted Total Ops | -5.70 | 0.70 | -0.60 | 0.80 | 1.30 |
| EPS Diluted Continuous Ops | -5.67 | 0.71 | 0.20 | 1.50 | 1.80 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.80 | -0.70 | -0.50 |
| EBITDA(a) | $2,946 | $10,557 | $5,572 | $12,088 | $12,823 |